Abstract
In this issue of Cell Chemical Biology, Pisa et al. (2020) find that haploid and diploid cells differentially develop resistance to the CENP-E inhibitor GSK923295. The results highlight the power of tumor cells to evade growth inhibition and potentially inform the design of next-generation CENP-E drugs to overcome resistance.
Original language | English |
---|---|
Pages (from-to) | 770-772 |
Number of pages | 3 |
Journal | Cell Chemical Biology |
Volume | 27 |
Issue number | 7 |
DOIs |
|
State | Published - 16 Jul 2020 |